These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7820228)

  • 41. Blood grouping with monoclonal anti-N antibodies.
    Fletcher A; Harbour C; Matthews M; de Zwart R; Ford D
    Aust J Exp Biol Med Sci; 1986 Jun; 64 ( Pt 3)():215-22. PubMed ID: 3767762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Phenotyping Kell and Duffy antigens by a technic of coagglutination on the Groupamatic G 360].
    Soustelle B; Rubio F; Coves F; Bizot M
    Rev Fr Transfus Immunohematol; 1982 Jun; 25(3):309-19. PubMed ID: 7111980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the presence or absence of J chain on expression of recombinant anti-Kell immunoglobulin M.
    Gilmour JE; Pittman S; Nesbitt R; Scott ML
    Transfus Med; 2008 Jun; 18(3):167-74. PubMed ID: 18598279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A McLeod phenotype detected by random screening for K:-4 [Kp(b-)] blood donors in Brazil.
    Wendel S; Fontão-Wendel R; Levi JE; Aravechia MG; Bordokan RF; Russo D; Haddad MS
    Transfusion; 2004 Nov; 44(11):1579-87. PubMed ID: 15504163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hybridomas specific for carbohydrates; synthetic human blood group antigens for the production, selection, and characterization of monoclonal typing reagents.
    Bundle DR; Gidney MA; Kassam N; Rahman AF
    J Immunol; 1982 Aug; 129(2):678-2. PubMed ID: 6177774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human monoclonal anti-D with reactivity against category DVI cells used in blood grouping and determination of the incidence of the category DVI phenotype in the DU population.
    Leader KA; Kumpel BM; Poole GD; Kirkwood JT; Merry AH; Bradley BA
    Vox Sang; 1990; 58(2):106-11. PubMed ID: 2111059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of panagglutinating sera.
    Branch DR
    Transfusion; 2010 Mar; 50(3):739-40; author reply 740. PubMed ID: 20609203
    [No Abstract]   [Full Text] [Related]  

  • 48. Group A variants defined with a monoclonal anti-A reagent.
    Lau P; Sererat S; Beatty J; Oilschlager R; Kini J
    Transfusion; 1990 Feb; 30(2):142-5. PubMed ID: 2106177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. K23. A low-incidence antigen in the Kell blood group system identified by biochemical characterization.
    Marsh WL; Redman CM; Kessler LA; DiNapoli J; Scarborough AL; Philipps AG; Mody KM
    Transfusion; 1987; 27(1):36-40. PubMed ID: 3810821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of a hospital-laboratory workstation for immunohematologic methods.
    Schoenfeld H; Pretzel KJ; von Heymann C; Neuner B; Kalus U; Kiesewetter H; Pruss A
    Transfusion; 2010 Jan; 50(1):26-31. PubMed ID: 19709392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A preliminary study of the distribution of blood group systems in Thai blood donors determined by the gel test.
    Nathalang O; Kuvanont S; Punyaprasiddhi P; Tasaniyanonda C; Sriphaisal T
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):204-7. PubMed ID: 11485086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunochemical characterization of a monoclonal anti-Leb blood grouping reagent.
    Messeter L; Brodin T; Chester MA; Karlsson KA; Zopf D; Lundblad A
    Vox Sang; 1984; 46(2):66-74. PubMed ID: 6702144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
    Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lectins as markers for blood grouping.
    Khan F; Khan RH; Sherwani A; Mohmood S; Azfer MA
    Med Sci Monit; 2002 Dec; 8(12):RA293-300. PubMed ID: 12503049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes.
    Denomme GA; Van Oene M
    Transfusion; 2005 May; 45(5):660-6. PubMed ID: 15847652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Kmod blood group phenotype in a healthy individual.
    Winkler MM; Beattie KM; Cisco SL; Sigmund KE; Johnson CL; Rabin BI; Marsh WL
    Transfusion; 1989 Sep; 29(7):642-5. PubMed ID: 2773032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Another example of mimicking anti-Kpb in a Kp(a+b-) patient.
    Puig N; Carbonell F; Marty ML
    Vox Sang; 1986; 51(1):57-9. PubMed ID: 3739324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a PCR-based diagnostic assay for the determination of KEL genotype in donor blood samples.
    Murphy MT; Fraser RH; Goddard JP
    Transfus Med; 1996 Jun; 6(2):133-7. PubMed ID: 8809961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of weak D with a fully automated solid-phase red cell adherence system.
    Lai M; Mavilia G; d'Onofrio G; Leone G
    Transfusion; 2005 May; 45(5):689-93. PubMed ID: 15847655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.